Google Glass eyes more significant role in healthcare

Google is hoping to become a bigger player in healthcare with recent improvement to Google Glass. A recent blog post, published by project lead Jay Kothari, showcased improvements to Glass aimed at integration into healthcare.

On top of a more comfortable design and extended battery life, Google Glass has utilized customized software to integrate itself into different industries. Kothari explained how the Glass is assisting healthcare professionals.

“Doctors at Dignity Health have been using Glass with an application our partner Augmedix calls 'a remote scribe.' Now, instead of typing on a computer during consultations, they can connect with patients by looking them in the eye, listening as they talk, and asking questions — all with confidence that all the note taking work is being done in the background,” Kothari wrote. “Dignity’s Chief Medical Information Officer, Dr. Davin Lundquist says that in addition to improving their quality of care, Glass has also reduced the time they spend typing up patient notes and other administrative work from 33 percent of their day to less than 10 percent, while doubling the amount of time they interact with patients.”

Read the full post below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.